bioMerieux's total assets for Q4 2025 were €5.57B, an increase of 3.88% from the previous quarter. FR:BIM total liabilities were €1.47B for the fiscal quarter, a 2.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.